Indaptus Therapeutics, Inc. (NASDAQ:INDP – Get Free Report) major shareholder Glen R. Anderson acquired 23,934 shares of the business’s stock in a transaction on Monday, August 14th. The stock was purchased at an average cost of $2.34 per share, with a total value of $56,005.56. Following the acquisition, the insider now directly owns 1,190,400 shares […]
HC Wainwright Comments on Indaptus Therapeutics, Inc s Q3 2023 Earnings (NASDAQ:INDP) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright reissued their buy rating on shares of Indaptus Therapeutics (NASDAQ:INDP – Free Report) in a research note published on Tuesday, Benzinga reports. HC Wainwright currently has a $12.00 price target on the stock. Indaptus Therapeutics Trading Up 0.6 % Shares of NASDAQ INDP traded up $0.01 during mid-day trading on Tuesday, hitting $1.80. […]
Indaptus Therapeutics, Inc. (NASDAQ:INDP – Get Free Report)’s stock price was down 4.5% on Tuesday . The stock traded as low as $1.90 and last traded at $1.90. Approximately 3,417 shares changed hands during mid-day trading, a decline of 82% from the average daily volume of 18,549 shares. The stock had previously closed at $1.99. […]
Shares of Indaptus Therapeutics, Inc. (NASDAQ:INDP – Get Rating) fell 0.5% on Friday . The stock traded as low as $1.84 and last traded at $1.95. 24,486 shares were traded during mid-day trading, an increase of 21% from the average session volume of 20,277 shares. The stock had previously closed at $1.96. Analysts Set New […]